drugset / Trial / NCT04401345

Effect of Glycopyrrolate on Vasopressors Requirement for Non-elective Caesarean Section Under Spinal Anaesthesia

NCT04401345

Phase 4 Completed 258 enrolled Rajesh Deshar
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is prospective randomised double blind study conducted in parturients planned for non-elective caesarean section under spinal anaesthesia. Glycopyrrolate group will receive 0.2 mg of Glycopyrrolate before start of phenylephrine infusion. Control group will receive 0.2 ml of Normal Saline before start of phenylephrine infusion. Total amount of vasopressors required i.e. ephedrine or phenylephrine will recorded in the form of phenylephrine equivalent during intraoperative period.

Timeline

Start
2020-06-01
Primary completion
2021-01-31
Completion
2021-01-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrrolate Small molecule 0.2 mg Intravenous

Indications

No indication recorded.